Hydroxyurea for children with sickle cell disease.

Hematology/oncology Clinics of North America
Matthew M Heeney, Russell E Ware

Abstract

Hydroxyurea therapy offers promise for ameliorating the clinical course of children with sickle cell disease (SCD). Hydroxyurea is a prototypic therapeutic option; it can be administered with minimal side effects, has a relatively wide therapeutic window, and has mechanisms of action that address pathophysiologic pathways of sickling, vaso-occlusion, hemolysis, and organ damage. There are limited data regarding hydroxyurea's ability to prevent or diminish organ dysfunction, and the long-term risks of hydroxyurea therapy remain incompletely defined. Although clinical trials are underway to address long-term issues, hydroxyurea remains an effective but underutilized therapy for SCD.

References

Jul 4, 1991·The New England Journal of Medicine·O S PlattT R Kinney
Jul 1, 1987·American Journal of Medical Genetics·D J OdenheimerC F Sing
Jul 1, 1987·Archives of Internal Medicine·K F BaumG R Serjeant
Mar 1, 1980·The Journal of Clinical Investigation·D R PowarsS P Azen
Apr 5, 1984·The New England Journal of Medicine·N L LetvinD G Nathan
Aug 1, 1984·The Journal of Clinical Investigation·O S PlattD G Nathan
Mar 1, 1993·Baillière's Clinical Haematology·W G Wood
Jun 15, 1995·The New England Journal of Medicine·G D SherN F Olivieri
Jun 9, 1994·The New England Journal of Medicine·O S PlattP P Klug
Jun 1, 1996·The Journal of Pediatrics·J P ScottR J Labotka
Oct 1, 1996·The Journal of Pediatrics·S JayaboseP Visintainer
Dec 22, 1999·Pharmacotherapy·D C ByrdC K Alexander
Jan 13, 2000·The New England Journal of Medicine·S T MillerT R Kinney
Dec 18, 2001·The Journal of Pediatrics·W C WangR E Ware
Feb 14, 2002·British Journal of Haematology·Mark T GladwinGriffin P Rodgers
Feb 28, 2002·The Journal of Pediatrics·Winfred C WangThomas R Kinney
Nov 1, 2002·American Journal of Hematology·Abraham SumozaVirgil Fairbanks
Dec 7, 2002·Journal of Pediatric Hematology/oncology·Linda M S ResarGeorge J Dover
Jan 25, 2003·British Journal of Haematology·Christina Halsey, Irene A Roberts
Mar 19, 2003·Blood Reviews·Sally C Davies, Annette Gilmore
Apr 4, 2003·JAMA : the Journal of the American Medical Association·Martin H SteinbergMichael Terrin
Nov 25, 2003·American Journal of Hematology·William H Schultz, Russell E Ware
Feb 27, 2004·The New England Journal of Medicine·Mark T GladwinFrederick P Ognibene
Mar 12, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Brandon L Maples, Tracy M Hagemann
Apr 16, 2004·American Journal of Perinatology·Ozlem PataSaffet Dilek
May 6, 2004·Journal of Pediatric Hematology/oncology·Matthew M HeeneyRussell E Ware
Jun 11, 2004·The New England Journal of Medicine·Elizabeth S Klings, Harrison W Farber
Aug 13, 2004·American Journal of Hematology·Sara T O SaadValder R Arruda
Feb 11, 2005·Pediatric Blood & Cancer·Courtney D FitzhughRussell E Ware
Mar 22, 2005·Journal of Clinical Pharmacology·Jing-He YanEugene Orringer
Mar 10, 2006·Pediatric Blood & Cancer·Tonya KratovilCaterina P Minniti
Apr 25, 2006·Free Radical Biology & Medicine·Jinming HuangS Bruce King
Mar 3, 2007·International Urology and Nephrology·Junaid MasoodJayanta M Barua
Apr 1, 1948·The American Journal of the Medical Sciences·J WATSON

❮ Previous
Next ❯

Citations

Nov 29, 2012·Pediatric Cardiology·Arpan R Doshi, Linda B Pauliks
Mar 5, 2011·Current Opinion in Hematology·Patrick T McGann, Russell E Ware
Sep 24, 2011·Journal of Pediatric Hematology/oncology·Masanori HayashiCourtney Thornburg
May 3, 2011·Nursing Research·Marsha J TreadwellW Thomas Boyce
Oct 12, 2013·International Health·N GaladanciA D Adekile
Dec 25, 2010·Seminars in Pediatric Neurology·Catherine Amlie-Lefond, Joan Cox Gill
May 6, 2011·British Journal of Haematology·Patrick T McGannRussell E Ware
Mar 16, 2013·European Journal of Haematology·Sharef Waadallah SharefYasser Wali
Nov 7, 2012·Pediatric Blood & Cancer·Suzette O OyekuNancy S Green
Jan 24, 2014·Pediatric Blood & Cancer·Courtney L VetterCharles T Quinn
May 7, 2014·European Journal of Haematology·Kerri A NottageBanu Aygun
Aug 19, 2014·Pediatric Blood & Cancer·Jeremie H EsteppJane S Hankins
Mar 27, 2015·American Journal of Hematology·Erica B EsrickBenjamin L Ebert
Sep 9, 2016·British Journal of Haematology·Kerri A NottageKathleen J Helton
Oct 28, 2016·Expert Review of Medical Devices·Yunus AlapanUmut A Gurkan
May 4, 2017·The New England Journal of Medicine·Kenneth I AtagaJulie Kanter
Sep 16, 2017·American Journal of Hematology·Jeremie H EsteppJane S Hankins
Feb 12, 2019·Pediatric Blood & Cancer·Elena María Rincón-LópezUNKNOWN RETRO-DREP Study Group
Jul 6, 2019·The Cochrane Database of Systematic Reviews·Monika R AsnaniAmza Ali
Jul 6, 2011·British Journal of Haematology·Lucio LuzzattoLéon Tshilolo
Jan 12, 2019·Advances in Hematology·Eugenia V AsareEdeghonghon Olayemi
Nov 19, 2010·Pediatric Hematology and Oncology·Yasser A Wali, Hisham Moheeb
Dec 8, 2020·The New England Journal of Medicine·Erica B EsrickDavid A Williams
Mar 3, 2021·Orphanet Journal of Rare Diseases·Nirmani YasaraSachith Mettananda
Nov 12, 2018·Mayo Clinic Proceedings·Sargam KapoorLydia H Pecker
Jul 18, 2021·British Journal of Haematology·Andrew M HeitzerJane S Hankins
Jul 6, 2021·Current Opinion in Pulmonary Medicine·Clare C Prohaska, Roberto F Machado
Feb 25, 2021·Journal of Pediatric Hematology/oncology·Julie KanterRobert J Adams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.